NCT02915484

Brief Summary

The purpose of this study is to test the efficacy and safety of tDCS (Transcranial Direct Current Stimulation) on apathy in stroke patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 27, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

October 3, 2017

Status Verified

September 1, 2017

Enrollment Period

1 year

First QC Date

September 20, 2016

Last Update Submit

September 29, 2017

Conditions

Keywords

Transcranial Direct Current StimulationApathyStrokeEmpathyElectric Stimulation TherapyDepressionAnhedoniaPrefrontal CortexElectroencephalographyCognitionEmotionsNeurological RehabilitationBrain DiseasesCerebrovascular Disorders

Outcome Measures

Primary Outcomes (1)

  • Changes in Apathy Inventory Scale - Clinician

    at the beginning of each session and 1 day after each session.

Secondary Outcomes (6)

  • Changes in Apathy Inventory Scale - Subject

    before and after each stimulation within 2 hours.

  • Changes in Apathy Inventory Scale - Family/Caregiver

    at the beginning of each session and 1 day after each session.

  • Actimeter

    Actimeter is worn from the beginning of the study to end of study (20 to 30 days)

  • Changes in Language Analysis tests

    before and after each stimulation within 2 hours.

  • Changes in Cognitive Tasks

    before and after each stimulation within 2 hours.

  • +1 more secondary outcomes

Study Arms (2)

tDCS stimulation A

EXPERIMENTAL

Intervention: Transcranial Direct Current Stimulation (tDCS) Up to 20 minutes of tDCS applied to the prefrontal cortex.

Device: Transcranial Direct Current Stimulation

tDCS stimulation B

EXPERIMENTAL

Intervention: Transcranial Direct Current Stimulation (tDCS) Up to 20 minutes of tDCS applied to the prefrontal cortex.

Device: Transcranial Direct Current Stimulation

Interventions

TDCS involves sending a weak electrical current to the brain to modulate brain functions.

Also known as: Neuroelectrics Starstim
tDCS stimulation AtDCS stimulation B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of stroke and radiographically proven ischemic or hemorrhagic stroke (MRI required for ischemic stroke, CT sufficient for hemorrhagic stroke)
  • Stroke occurred at least one month prior to first stimulation session
  • Ability to provide informed consent
  • Availability of a family member / caregiver who knew the subject before the stroke and interacts with the subject on at least a weekly basis
  • Score of 6 or higher in initial apathy testing using Apathy Inventory - Clinician score
  • Speak English (required for quantifying apathy and performing the cognitive tests)

You may not qualify if:

  • Other potential cause of apathy including some neurodegenerative diseases, some psychiatric diseases, and anti-dopamine medication
  • Prior brain injury (e.g., Traumatic Brain Injury (TBI), stroke) without full motor and cognitive recovery based on patient, family or clinician report
  • Active medical illness (e.g., infection, delirium, etc.) that might affect arousal and cognitive function
  • Hypoarousal (inability to maintain eye opening without stimulation) from any cause (e.g., stroke, sleep deprivation)
  • Any history of epilepsy
  • Recent drug or alcohol abuse - within the past year
  • Pregnant or breastfeeding
  • Moderate to severe aphasia preventing subject from communicating fully
  • Any pacemakers, intracranial electrodes, implanted defibrillators, or any other electrical implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stony Brook University

Stony Brook, New York, 11794, United States

Location

Related Publications (2)

  • Brunoni AR, Nitsche MA, Bolognini N, Bikson M, Wagner T, Merabet L, Edwards DJ, Valero-Cabre A, Rotenberg A, Pascual-Leone A, Ferrucci R, Priori A, Boggio PS, Fregni F. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul. 2012 Jul;5(3):175-195. doi: 10.1016/j.brs.2011.03.002. Epub 2011 Apr 1.

    PMID: 22037126BACKGROUND
  • Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull. 2007 May 30;72(4-6):208-14. doi: 10.1016/j.brainresbull.2007.01.004. Epub 2007 Jan 24.

    PMID: 17452283BACKGROUND

MeSH Terms

Conditions

LethargyStrokeDepressionAnhedoniaBrain DiseasesCerebrovascular Disorders

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Andrew M Goldfine, MD

    Stony Brook Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 20, 2016

First Posted

September 27, 2016

Study Start

June 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

October 3, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share

Locations